Found 8 results
Name | Type of Offering | Accepted Date |
---|---|---|
Cyclacel Pharmaceuticals, Inc.
|
D | 2024-11-26 06:38:15 |
Amount To Be Raised
$2,062,112
Associated Brokers / Dealers
N/A
CIK Number
0001130166
Filed Document
0001104659-24-122795
Exclusions or Exemptions
506b
Accepted Date
2024-11-26 06:38:15
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Cyclacel Pharmaceuticals, Inc.
|
D | 2010-10-21 |
Amount To Be Raised
$22,150,089
Associated Brokers / Dealers
N/A
CIK Number
0001130166
Filed Document
0001209191-10-051298
Exclusions or Exemptions
N/A
Accepted Date
2010-10-21
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Cyclacel Pharmaceuticals, Inc.
|
D | 2025-02-14 16:56:28 |
Amount To Be Raised
N/A
Associated Brokers / Dealers
N/A
CIK Number
0001130166
Filed Document
0001829126-25-001006
Exclusions or Exemptions
506b
Accepted Date
2025-02-14 16:56:28
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Cyclacel Pharmaceuticals, Inc.
|
D | 2012-04-30 |
Amount To Be Raised
$3,036,000
Associated Brokers / Dealers
N/A
CIK Number
0001130166
Filed Document
0001104659-12-031372
Exclusions or Exemptions
N/A
Accepted Date
2012-04-30
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Cyclacel Pharmaceuticals, Inc.
|
D | 2025-02-14 16:56:59 |
Amount To Be Raised
$25,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001130166
Filed Document
0001829126-25-001007
Exclusions or Exemptions
506b
Accepted Date
2025-02-14 16:56:59
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Cyclacel Pharmaceuticals, Inc.
|
D | 2021-01-04 10:54:42 |
Amount To Be Raised
$7,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001130166
Filed Document
0001780314-21-000001
Exclusions or Exemptions
506b
Accepted Date
2021-01-04 10:54:42
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Cyclacel Pharmaceuticals, Inc.
|
D | 2024-05-17 09:56:58 |
Amount To Be Raised
$8,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001130166
Filed Document
0001104659-24-062806
Exclusions or Exemptions
506b
Accepted Date
2024-05-17 09:56:58
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Cyclacel Pharmaceuticals, Inc.
|
D | 2025-03-25 14:19:16 |
Amount To Be Raised
$1,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001130166
Filed Document
0001829126-25-002044
Exclusions or Exemptions
506b
Accepted Date
2025-03-25 14:19:16
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NEW JERSEY
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|